Nitrofurantoína y enfermedad pulmonar intersticial de rápida resolución
Miguel Ángel Núñez Viejo(Universidad de Cantabria), José L. Hernández(Universidad de Cantabria), C. García Ibarbia(Universidad de Cantabria), Javier Velasco Montes(Universidad de Cantabria), Ana Montes(Guy's and St Thomas' NHS Foundation Trust)
Cited by 4
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor
|Gynecologic Oncology|2019|104
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
|British Journal of Cancer|2022|89